Although the seroconversion to islet autoantibody positivity has been the first detectable signal for the onset of autoimmunity and progression towards diabetes [2], the initiators of autoimmune response, mechanisms regulating progress toward beta cell failure and factors determining time of presentation of clinical diabetes are poorly understood.
Thus, taken together, the phenotypic and molecular data suggest this cluster of genes functions as a linear pathway to regulate progress of Yor1 out of the ER and through the Golgi for delivery to the plasma membrane.
Its importance was underlined in a number of recommendations, as well as in The Convention on Human Rights and Biomedicine, which regulates this progress but does not stop it.
Until then, the real dangers of human civilization lurk in those who want to hinder or over-regulate progress.
These data thus provide in vivo evidence for the presence and a role of unliganded TR-induced gene repression in physiological settings and strongly support our earlier model that unliganded TR represses T3-response genes in premetamorphic tadpoles to regulate the progress of development.
Nevertheless it must, it seems, reject the full-on scientific realist commitment to the idea that the history of science is regulated by progress towards some final and unassailable set of scientifically established truths about nature, by a journey towards, as it were, God's science (Haugeland 2007).
To regulate the progress of oogenesis and embryogenesis, stored maternal mRNAs are translationally repressed during early oocyte development.
According to these results, we concluded that some proliferation-related signalling pathways must have taken part in the cell cycle and regulated the progress of proliferation 74– 74.
In eukaryote, AGO proteins are conserved gene family and the core part in all-known small-RNA-directed regulatory pathways which regulate developmental progress by repressing expression of the target genes [ 13, 18].
In the past decades, many microRNAs such as miR-21, miR-155, miR-16, and miR-218 have been found to regulate the progress of gliomas (Yang et al. 2014a, b; Yanyang et al. 2013; Zhou et al. 2013).
